Published: Fri, November 23, 2018
Medical | By Vernon Walton

Insulin shortage to affect 40 million people by 2030

Insulin shortage to affect 40 million people by 2030

Projection Stanford University researchers developed a microsimulation of type 2 diabetes management from 2018-2030 across 221 countries using data from the International Diabetes Federation.

The study predicts that African, Asian, and Oceania regions will not get the proper amount of insulin in 2030 if the access remains at current levels.

By 2030, an estimated 79 million adults with Type 2 diabetes are expected to need insulin.

The expected increase in the demand of insulin in the coming 12 years, and the incidence of type-2 diabetes, signalled grave shortage of insulin to treat the patients. Study Says The Ketogenic Diet Could Increase The Risk For Type 2 Diabetes.


Almost 98 million people in India may have type 2 diabetes by 2030, according to a study, which found that the number of adults with the disease worldwide is expected rise by over a fifth.

According to a new study, these changes will cause a dramatic increase in the number of people living with diabetes. As per the study report, 79 million people will need insulin to manage diabetes and out of this enormous number, more than half will find it hard to obtain this drug.

Dr. Sanjay Basu from Stanford University in the United States said that these approximates proposes that present level of insulin retrieval are extremely scanty contrasted to estimated requirement especially in Africa and Asia, and more attempts should be committed to vanquishing this emerging health provocation.

The Guardian quoted Dr. Sanjay Basu from Stanford University in the USA, who led the research, as saying the current levels of insulin access are inadequate especially in Africa and Asia, requiring more efforts to overcome this shortage. Only three manufacturers control most of the insulin supply of the world, all of which were accused of conspiring to hike prices intentionally.


Diabetes affects more than 382 million people worldwide. The cost is one of the main reason as the price of insulin had already tripled between 2002 and 2013. "Except if governments start activities to make insulin accessible and affordable, at that point its utilization is continually going to be a long way from optimal".

The researchers have warned that new strategies must be adopted to make insulin more widely available and affordable.

A recent study projects the global need for insulin in the future.


Like this: